Statin Therapy Results in the Real World Practice in the Czech Republic

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01055977

Acronym

STEP

Enrollment

3253

Registered

2010-01-26

Start date

2010-02-28

Completion date

2010-06-30

Last updated

2011-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidaemia

Keywords

statin therapy, treatment goal, dyslipidaemia

Brief summary

Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels. The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Documented statin therapy for at least 12 months * Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
LDL-C	one year

Secondary

Measure	Time frame
Total cholesterol	one year
HDL-C	one year
triglycerides	one year

Countries

Czechia

Outcome results